• 1
    Parkin D. M., International variation, Oncogene, 23: 63296340, 2004.
  • 2
    Stewart S. L., King J. B., Thompson T. D., Friedman C., Wingo P. A., Cancer mortality surveillance–United States, 1990–2000, MMWR. Surveill. Summ., 53: 1108, 2004.
  • 3
    Jemal A., Thomas A., Murray T., Thun M., Cancer statistics, 2002, CA Cancer. J.Clin., 52: 2347, 2002.
  • 4
    Bray F., Sankila R., Ferlay J., Parkin D. M., Estimates of cancer incidence and mortality in Europe in 1995, Eur. J. Cancer, 38: 99166, 2002.
  • 5
    Edwards B. K., Howe H. L., Ries L. A., Thun M. J., Rosenberg H. M., Yancik R., Wingo P. A., Jemal A., Feigal E. G., Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and againg on U.S. Cancer burden, Cancer, 94: 27662792, 2002.
  • 6
    Hulka B. S., Moorman P. G., Breast cancer: hormones and other risk factor, Maturitas, 38: 103113, 2001.
  • 7
    Pike M. C., Spicer D. V., Dahmoush L., Press M. F., Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk, Epidemiol. Rev., 15: 1735, 1993.
  • 8
    Parkin D. M., Pisani P., Ferlay J., Global cancer statistics, CA Cancer J. Clin., 49: 3364, 1, 1999.
  • 9
    Ziegler R. G., Hoover R. N., Pike M. C., Hildesheim A., Nomura A. M., West D. W., Wu-Williams A. H., Kolonel L. N., Horn-Ross P. L., Rosenthal J. F., Migration Patterns and breast cancer risk in Asian-American women, J. Natl. Cancer Inst., 85: 18191827, 1993.
  • 10
    McPherson K., Steel C. M., Dixon J. M., ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics, BMJ, 321: 624628, 2000.
  • 11
    Robert S. A., Strombom I., Trentham-Dietz A., Hampton J. M., McElroy J. A., Newcomb P. A., Remington P. L., Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects, Epidemiology, 15: 442450, 2004.
  • 12
    Feigelson H. S., Henderson B. E., Estrogens and breast cancer, Carcinogenesis, 17: 22792284, 1996.
  • 13
    Berkey C. S., Frazier A. L., Gardner J. D., Colditz G. A., Adolescence and breast carcinoma risk, Cancer, 85: 24002409, 1999.
  • 14
    Kelsey J. L., Gammon M. D., John E. M., Reproductive factors and breast cancer, Epidemiol.Rev., 15: 3647, 1993.
  • 15
    Titus-Ernstoff L., Longnecker M. P., Newcomb P. A., Dain B., Greenberg E. R., Mittendorf R., Stampfer M., Willett W., Menstrual factors in relation to breast cancer risk, Cancer Epidemiol.Biomarkers Prev., 7: 783789, 1998.
  • 16
    Brinton L. A., Schairer C., Hoover R. N., Fraumeni J. F., Jr., Menstrual factors and risk of breast cancer, Cancer Invest, 6: 245254, 1988.
  • 17
    Bernstein L., Epidemiology of endocrine-related risk factors for breast cancer, J. Mammary. Gland. Biol. Neoplasio., 7: 315, 2002.
  • 18
    Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with brest cancer and 100 239 women without breast cancer form 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer, Lancet, 347: 17131727, 1996.
  • 19
    Kreiger N., Sloan M., Cotterchio M., Kirsh V., The risk of breast cancer following reproductive surgery, European Journal of Cancer, 35: 97101, 1999.
  • 20
    Russo J., Hu Y. F., Yang X., Russo I. H., Developmental, cellular, and molecular basis of human breast cancer, J. Natl. Cancer. Inst. Monogr., 1737, 2000.
  • 21
    Pathak D. R., Osuch J. R., He J., Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations, Cancer, 88: 12301238, 2000.
  • 22
    Lambe M., Hsieh C., Trichopoulos D., Ekbom A., Pavia M., Adami H. O., Transient increase in the risk of breast cancer after giving birth, N. Engl. J. Med., 331: 59, 1994.
  • 23
    Helewa M., Levesque P., Provencher D., Lea R. H., Rosolwich V., Shapiro H. M., Breast cancer, pregnancy, and breastfeeding, J. Obstet. Gynaecol. Can., 24: 164180, 2002.
  • 24
    Lipworth L., Bailey L. R., Trichopoulos D., History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature, J. Natl. Cancer. Inst., 92: 302312, 2000.
  • 25
    Beral V., Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease, The Lancet, 360; 187195, 2002.
  • 26
    Sivaraman L., Medina D., Hormone-induced protection against breast cancer, J. Mammary. Glangd. Biol. Neoplasia., 7: 7792, 2002.
  • 27
    Ross R. K., Paganini-Hill A., Wan P. C., Pike M. C., Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin, J. Natl. Cancer Inst., 92: 328332, 2000.
  • 28
    Fisher B., Costantino J. P., Wickerham D. L., Redmond C. K., Kavanah M., Cronin W. M., Vogel V., Robidoux A., Dimitrov N., Atkins J., Daly M., Wieand S., Tan-Chiu E., Ford L., Wolmark N., Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel and Project P-1 Study, J. Natl. Cancer Inst., 90: 13711388, 1998.
  • 29
    Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer, Lancet, 350: 10471059, 1997.
  • 30
    Rossouw J. E., Anderson G. L., Prentice R. L., LaCroix A. Z., Kooperberg C., Stefanick M. L., Jackson R. D., Beresford S. A., Howard B. V., Johnson K. C., Kotchen J. M., Ockene J., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal resutls From the Women's Health Initiative randomized controlled trial, JAMA, 288: 321333, 2002.
  • 31
    Schairer C., Lubin J., Troisi R., Sturgeon S., Brinotn L., Hoover R., Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk, JAMA, 283: 485491, 2000.
  • 32
    Magnusson C., Baron J. A., Correia N., Bergstrom R., Adami H. O., Persson I., Breast-cancer risk followilng long-term oestrogen- and oestrogen-progestin-replacement therapy, Int. J. Cancer., 81: 339334, 1999.
  • 33
    Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer, Contraception, 54: 1S106S, 1996.
  • 34
    Grabrick D. M., Hartmann L. C., Cerhan J. R., Vierkant R. A., Therneau T. M., Vachon C. M., Olson J. E., Couch F. J., Anderson K. E., Pankratz V. S., Sellers T. A., Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer, JAMA, 284: 17911798, 2000.
  • 35
    Heimdal K., Skovlund E., Moller P., Oral contraceptives and risk of familial breast cancer, Cancer. Detect. Prev., 26: 2327, 2002.
  • 36
    Singletary K. W., Gapstur S. M., Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms, JAMA, 286: 21432151, 2001.
  • 37
    Smith-Warner S. A., Spiegelamn D., Yaun S. S., van den Brandt P. A., Folsom A. R., Goldbohm R. A., Graham S., Holmberg L., Howe G. R., Marshall J. R., Miller A. B., Poter J. D., Speizer F. E., Willett W. C., Wolk A., Hunter D. J., Alcohol and breast cancer in women: a pooled analysis of cohort studies, JAMA, 279: 535540, 1998.
  • 38
    Poschl G., Seitz H. K., Alcohol and cancer, Alcohol Alcohol, 39: 155165, 2004.
  • 39
    Reichman M. E., Judd J. T., Longcope C., Schatzkin A., Clevidence B. A., Nair P. P., Campbell W. S., Taylor P. R., Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women, J. Natl. Cancer Inst., 85: 722727, 1993.
  • 40
    Coutelle C., Hohn B., Benesova M., Oneta C. M., Quattrochi P., Roth H. J., Schmidt-Gayk H., Schneeweiss A., Bastert G., Seitz H. K., Risk factors in alcohol associated breast cancer: alcohol dehydrogenase polymorphism and estrogens, Int. J. Oncol., 25: 11271132, 2004.
  • 41
    Ginsburg E. S., Walsh B. W., Gao X., Gleason R. E., Feltmate C., Barbieri R. L., The effect of acute ethanol ingestion on estrogen levels in postmenopausal women using transdermal estradiol, J. Soc. Gynecol. Investig., 2: 2629, 1995.
  • 42
    Onland-Moret N. C., Peeters P. H., van der Schouw Y. T., Grobbee D. E., Van Gils C. H., Alcohol and Endogenous Sex Steroid Levels in Postmenopausal Women: a cross-sectional study, J. Clin. Endocrinol. Metab., 2004.
  • 43
    Sellers T. A., Vierkant R. A., Cerhan J. R., Gapstur S. M., Vachon C. M., Olson J. E., Pankratz V. S., Kushi L. H., Folsom A. R., Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women, Cancer Epidemiol. Biomarkers Prev., 11: 11041107, 2002.
  • 44
    Duthie S. J., Folic acid deficiency and cancer: mechanisms of DNA instability, Br. Med. Bull., 55: 578592, 1999.
  • 45
    Zhang S. M., Role of vitamins in the risk, prevention, and treatment of breast cancer, Curr. Opin. Obstet. Gynecol., 16: 1925, 2004.
  • 46
    Sugimura T., Nutrition and dietary carcinogens, Carcinogenesis, 21: 387395, 2000.
  • 47
    Zheng W., Gustafson D. R., Sinha R., Cerhan J. R., Moore D., Hong C. P., Anderson K. E., Kushi L. H., Sellers T. A., Folsom A. R., Well-done meat intake and the risk of breast cancer, J. Natl. Cancer Inst., 90: 17241729, 1998.
  • 48
    Velie E., Kulldorff M., Schairer C., Block G., Albanes D., Schatzkin A., Dietary fat, fat subtypes, and breast cancer in postmenopausal women: a prospective cohort study, J. Natl. Cancer Inst., 92: 833839, 2000.
  • 49
    Bartsch H., Nair J., Owen R. W., Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers, Carcinogenesis, 20: 22092218, 1999.
  • 50
    Saadatian-Elahi M., Norat T., Goudable J., Riboli E., Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis, Int. J. Cancer, 111: 584591, 2004.
  • 51
    Van Duyn M. A., Pivonka E., Overview of the Health Benefits of Fruit and Vegetable Consumption for the Dietetics Professional: Selected Literature, J. Am. Diet Assoc., 100: 15111521, 2000.
  • 52
    Lee I. M., Antioxidant vitamins in the prevention of cancer, Proc. Assoc. Am. Physicians, 111: 1015, 1999.
  • 53
    Gaudet M. M., Britton J. A., Kabat G. C., Steck-Scott S., Eng S. M., Teitelbaum S. L., Terry M. B., Neugut A. I., Gammon M. D., Fruits, Vegetables, and Micronutrients in Relation to Breast Cancer Modified by Menopause and Hormone Receptor Status, Cancer Epidemiol. Biomarkers Prev., 13: 14851494, 2004.
  • 54
    Bouker K. B., Hilakivi-Clarke L., Genistein: does it prevent or promote breast cancer?, Environ. Health Perspect., 108: 701708, 2000.
  • 55
    Harris R. E., Namboodiri K. K., Wynder E. L., Breast cancer risk: effects of estrogen replacement therapy and body mass, J. Natl. Cancer Inst., 84: 15751582, 1992.
  • 56
    Huang Z., Hankinson S. E., Colditz G. A., Stampfer M. J., Hunter D. J., Manson J. E., Hennekens C. H., Rosner B., Speizer F. E., Willett W. C., Dual effects of weight and weight gain on breast cancer risk, JAMA, 278: 14071411, 1997.
  • 57
    Lahmann P. H., Hoffmann K., Allen N., Van Gils C. H., Khaw K. T., Tehard B., Berrino F., Tjonneland A., Bigaard J., Olsen A., Overvad K., Clavel-Chapelon F., Nagel G., Boeing H., Trichopoulos D., Economou G., Bellos G., Palli D., Tumino R., Panico S., Sacerdote C., Krogh V., Peeters P. H., Bueno-de-Mesquita H. B., Lund E., Ardanaz E., Amiano P., Pera G., Quiros J. R., Martinez C., Tormo M. J., Wirfalt E., Berglund G., Hallmans G., Key T. J., Reeves G., Bingham S., Norat T., Biessy C., Kaaks R., Riboli E., Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC), Int. J. Cancer, 111: 762771, 2004.
  • 58
    Friedenreich C. M., Review of anthropometric factors and breast cancer risk, Eur. J. Cancer Prev., 10: 1532, 2001.
  • 59
    Trentham-Dietz A., Newcomb P. A., Egan K. M., Titus-Ernstoff L., Baron J. A., Storer B. E., Stampfer M., Willett W. C., Weight change and risk of postmenopausal breast cancer (United States), Cancer Causes Control, 11: 533542, 2000.
  • 60
    McTiernan A., Rajan K. B., Tworoger S. S., Irwin M., Bernstein L., Baumgartner R., Gilliland F., Stanczyk F. Z., Yasui Y., Ballard-Barbash R., Adiposity and Sex Hormones in Postmeopausal Breast Cancer Survivors, J. Clin. Oncol., 21: 19611966, 2003.
  • 61
    Lagerros Y. T., Hsieh S. F., Hsieh C. C., Physical activity in adolescence and young adulthood and breast cancer risk: a quantitative review, Eur. J. Cancer Prev., 13: 512, 2004.
  • 62
    Hankinson S. E., Colditz G. A., Willett W. C., Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones, Breast Cancer Res., 6: 213218, 2004.
  • 63
    Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease, Lancet, 358: 13891399, 2001.
  • 64
    Brinton L. A., Hoover R., Haile R., Mammographic features and breast cancer risk: effects with time, age, and menopause status, J. Natl. Cancer Inst., 87: 16221629, 1995.
  • 65
    Boyd N. F., Byng J. W., Jong R. A., Fishell E. K., Little L. E., Miller A. B., Lockwood G. A., Tritchler D. L., Yaffe M. J., Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study, J. Natl. Cancer Inst., 87: 670675, 1995.
  • 66
    Biglia N., Defabiani E., Ponzone R., Mariani L., Marenco D., Sismondi P., Management of risk of breast carcinoma in postmenopausal women, Endocr: Relat. Cancer, 11: 6983, 2004.
  • 67
    Van Gils C. H., Hendriks J. H., Otten J. D., Holland R., Verbeek A. L., Parity and mammographic breast density in relation to breast cancer risk: indication of interaction, Eur: J. Cancer Prev., 9: 105111, 2000.
  • 68
    Sala E., Warren R., McCann J., Duffy S., Luben R., Day N., High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study, Int. J. Epidemiol., 29: 629636, 2000.
  • 69
    Cauley J. A., Gutai J. P., Kuller L. H., Scott J., Nevitt M. C., Black-white differences in serum sex hormones and bone mineral density, Am. J. Epidemiol., 139: 10351046, 1994.
  • 70
    van den Brandt P.A., Spiegelman D., Yaun S. S., Adami H. O., Beeson L., Folsom A. R., Fraser G., Goldbohm R. A., Graham S., Kushi L., Marshall J. R., Miller A. B., Rohan T., Smith-Warner S. A., Speizer F. E., Willett W. C., Wolk A., Hunter D. J., Pooled Analysis of Prospective Cohort Studies on Height, Weight, and Breast Cancer Risk, American Journal of Epidemiology, 152: 514527, 2000.
  • 71
    Renehan A. G., Zwahlen M., Minder C., O'Dwyer S. T., Shalet S. M., Egger M., Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis, Lancet, 363: 13461353, 2004.
  • 72
    Yu H., Shu X. O., Li B. D. L., Dai Q., Gao Y. T., Jin F., Zheng W., Joint Effect of Insulin-like Growth Factors and Sex Steriods on Breast Cancer Risk, Cancer Epidemiol. Biomarkers Prev., 12: 10671073, 2003.
  • 73
    Clevenger C. V., Furth P. A., Hankinson S. E., Schuler L. A., The role of prolactin in mammary carcinoma, Endocr. Rev, 24: 127, 2003.
  • 74
    Hankinson S. E., Willett W. C., Michaud D. S., Manson J. E., Colditz G. A., Longcope C., Rosner B., Speizer F. E., Plasma prolactin levels and subsequent risk of breast cancer in postmenopusal women, J. Natl. Cancer Inst., 91: 629634, 1999.
  • 75
    Cotarla I., Ren S., Zhang Y., Gehan E., Singh B., Furth P.A., Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers, Int. J. Cancer, 108: 665671, 2004.
  • 76
    Tobias J. S., J. S., Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention, Ann. Oncol., 15: 17381747, 2004.
  • 77
    Arun B., Goss P., The role of COX-2 inhibition in breast cancer treatment and prevention, Semin. Oncol., 31: 2229, 2004.
  • 78
    Easton D., Ford D., Peto J., Inherited susceptibility to breast cancer, Cancer Surv., 18: 95113, 1993.
  • 79
    Oesterreich S., Fuqua S. A., Tumor suppressor genes in breast cancer, Endocr. Relat. Cancer, 6: 405419, 1999.
  • 80
    Johnson- Thompson M. C., Guthrie J., Ongoing research to identify environmental risk factors in breast carcinoma, Cancer, 88: 12241229, 2000.
  • 81
    Rebbeck T. R., Inherited genetic predisposition in breast cancer. A population-based perspective, Cancer, 86: 24932501, 1999.
  • 82
    De Jong M. M., Nolte I. M., Te Meerman G. J., van der Graaf W. T., Oosterwijk J. C., Kleibeuker J. H., Schaapveld M., De Vries E. G., Genes Other than BRCA1 and BRCA2 involved in breast cancer susceptibility, J. Med. Genet., 39: 225242, 2002.
  • 83
    Deng C. X., Brodie S. G., Roles of BRCA1 and its interacting proteins, Bioessays, 22: 728737, 2000.
  • 84
    Narod S. A., Modifiers of risk of hereditary breast and ovarian cancer, Nat. Rev. Cancer, 2: 113123, 2002.
  • 85
    King M. C., Marks J. H., Mandell J. B., Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2, Science, 302: 643646, 2003.
  • 86
    Ford D., Easton D. F., Stratton M., Narod S., Goldgar D., Devilee P., Bishop D. T., Weber B., Lenoir G., Chang-Claude J., Sobol H., Teare M. D., Struewing J., Arason A., Scherneck S., Peto J., Rebbeck T. R., Tonin P., Neuhausen S., Barkardottir R., Eyfjord J., Lynch H., Ponder B. A., Gayther S. A., Zelada-Hedman M., Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium, Am. J. Hum. Genet., 62: 676689, 1998.
  • 87
    Osorio A., de la H. M., Rodriguez-Lopez R., Martinez-Ramirez A., Cazorla A., Granizo J.J., Esteller M., Rivas C., Caldes T., Benitez J., Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer, Int. J. Cancer, 99: 305309, 2002.
  • 88
    Eiriksdottir G., Barkardottir R. B., Agnarsson B. A., Johannesdottir G., Olafsdottir K., Egilsson V., Ingvarsson S., High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers, Oncogene, 16: 2126, 1998.
  • 89
    Venkitaraman A. R., Tracing the network connecting BRCA and Fanconi anaemia proteins, Nat. Rev. Cancer, 4: 266276, 2004.
  • 90
    Malkin D., Germline p53 mutations and heritable cancer, Annu. Rev. Genet., 28: 443465, 1994.
  • 91
    Garber J. E., Goldstein A. M., Kantor A. F., Dreyfus M. G., Fraumeni J. F., Jr., Li F.P., Follow-up study of twentyfour families with Li-Fraumeni syndrome, Cancer Res., 51: 60946097, 1991.
  • 92
    Easton D. F., The inherited component of cancer, Br. Med. Bull., 50: 527535, 1994.
  • 93
    Gorski B., Debniak T., Masojc B., Mierzejewski M., Medrek K., Cybulski C., Jakubowska A., Kurzawski G., Chosia M., Scott R., Lubinski J., Germline 657de15 mutation in the NBS1 gene in breast cancer patients, Int. J. Cancer, 106: 379381, 2003.
  • 94
    Rothman N., Wacholder S., Caporaso N. E., Garcia-Closas M., Buetow K., Fraumeni Jr. J.F., The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1471: C1C10, 2001.
  • 95
    Okobia M. N., Bunker C. H., Molecular epidemiology of breast cancer: a review, Afr. J. Reprod. Health, 7: 1728, 2003.
  • 96
    Bartsch H., Nair U., Risch A., Rojas M., Wikman H., Alexandrov K., Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers, Cancer Epidemiol. Biomarkers Prev., 9: 328, 2000.
  • 97
    Hellmold H., Rylander T., Magnusson M., Reihner E., Warner M., Gustafsson J. A., Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammaplasties, J. Clin. Endocrinol. Metab, 83: 886895, 1998.
  • 98
    Strange R. C., Fryer A. A., The glutathione S-transferases: influence of polymorphism on cancer susceptibility, IARC Sci. Publ., 231249, 1999.
  • 99
    Albin N., Massaad L., Toussaint C., Mathieu M. C., Morizet J., Parise O., Gouyette A., Chabot G. G., Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues, Cancer Res., 53: 35413546, 1993.
  • 100
    Gudmundsdottir K., Tryggvadottir L., Eyfjord J. E., GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene, Cancer Epidemiol. Biomakers Prev., 10: 11691173, 2001.
  • 101
    Freudenheim J. L., Ambrosone C. B., Moysich K. B., Vena J. E., Graham S., Marshall J. R., Muti P., Laughlin R., Nemoto T., Harty L. C., Crits G. A., Chan A. W., Shields P. G., Alcohol dehydrogenase 3 genotype modification of the association of alcohol consumption with breast cancer risk, Cancer Causes Control, 10: 369377, 1999.
  • 102
    Campbell I. G., Baxter S. W., Eccles D. M., Choong D. Y., Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer, Breast Cancer Res., 4: R142002.
  • 103
    Ergul E., Sazci A., Utkan Z., Canturk N. Z., Polymorphisms in the MTHFR gene are associated with breast cancer, Tumour. Biol., 24: 286290, 2003.
  • 104
    Duell E. J., Millikan R. C., Pittman G. S., Winkel S., Lunn R. M., Tse C. K., Eaton A., Mohrenweiser H. W., Newman B., Bell D. A., Polymorphisms in the DNA Repair Gene XRCC1 and Breast Cancer, Cancer Epidemiol. Biomarkers Prev. 10: 217222, 2001.
  • 105
    Smith T. R., Levine E. A., Perrier N. D., Miller M. S., Freimanis R. I., Lohman K., Case L. D., Xu J., Mohrenweiser H. W., Hu J. J., DNA-repair genetic polymorphisms and breast cancer risk, Cancer Epidemiol. Biomarkers Prev., 12: 12001204, 2003.
  • 106
    Goode E. L., Ulrich C. M., Potter J. D., Polymorphisms in DNA Repair Genes and Associations with Cancer Risk, Cancer Epidemiol. Biomarkers Prev., 11: 15131530, 2002.
  • 107
    Medina D, Breast cancer: the protective effect of pregnancy, Clin. Cancer Res., 10: 380S384S, 2004.